Reconstituted Tesamorelin Shelf Life: What Storage Listings Report

Reconstituted tesamorelin shelf life is the window that supplier and lab documentation typically describes between the moment bacteriostatic water is added to a lyophilized vial and the point at which the peptide solution is no longer considered stable for research use. That window is shaped by storage temperature, the diluent used, and how the vial is handled after mixing, and it is reported very differently from the shelf life of the unreconstituted, freeze-dried powder.

Why Reconstitution Changes the Timeline

Lyophilized tesamorelin is a dry, stabilized powder sealed under vacuum or inert gas. In that state, supplier documentation generally lists a shelf life measured in months when stored frozen or refrigerated and protected from light. Once bacteriostatic water is introduced, the peptide is in an aqueous environment, and peptide bonds are more exposed to hydrolysis, oxidation, and microbial contact. This is why reconstituted tesamorelin shelf life is reported in a much shorter unit — typically days to a few weeks — rather than the months associated with the sealed powder.

Bacteriostatic water contains a small percentage of benzyl alcohol, which is included specifically to inhibit bacterial growth after the vial’s rubber stopper has been punctured multiple times. Without that preservative, plain sterile water would carry a shorter practical handling window because nothing in the solution limits microbial growth between draws.

Storage Temperature and Reported Stability

Across supplier and lab-reference documentation, refrigeration is the most commonly cited storage condition for a reconstituted vial. Documentation generally distinguishes between three conditions:

Storage condition	Typical reported range	Notes commonly listed
Refrigerated (2-8°C)	Days to a few weeks	Most common storage recommendation post-reconstitution
Room temperature	Hours to a couple of days	Reported as reducing stability faster than refrigeration
Frozen (below 0°C)	Not typically recommended after mixing	Freeze-thaw cycling is described as a stability risk for reconstituted peptide solutions

These ranges vary by source, and none of them should be read as a guarantee — they reflect how documentation categorizes storage conditions relative to one another, not a fixed countdown that applies to every vial or every diluent ratio.

How Reconstitution Ratio Is Calculated

Reconstituted tesamorelin shelf life discussions often appear alongside concentration calculations, since the amount of diluent added determines how concentrated the resulting solution is. The relationship is:

concentration (mg/mL) = vial strength (mg) ÷ diluent volume added (mL)

As a worked example: a 5 mg vial reconstituted with 2 mL of bacteriostatic water yields a concentration of 5 ÷ 2 = 2.5 mg/mL. Converting to micrograms for reference, 2.5 mg/mL is equivalent to 2,500 mcg/mL, since 1 mg equals 1,000 mcg. On a U-100 insulin syringe, where the full barrel of 1 mL corresponds to 100 unit markings, each unit drawn on that syringe would represent 2.5 mg ÷ 100 = 0.025 mg, or 25 mcg, of the reconstituted solution. Recalculating a second time confirms the figures: 5 mg divided by 2 mL is 2.5 mg/mL, 2.5 mg/mL times 1,000 is 2,500 mcg/mL, and 2,500 mcg divided across 100 syringe units is 25 mcg per unit. A calculator such as peptcalc.com can be used to cross-check reconstitution math like this against a second source.

The diluent volume itself does not change how long the solution remains stable, but it does affect how concentration is tracked over the vial’s use, which is often discussed in the same breath as shelf life because both depend on accurate labeling of the vial after mixing.

Documentation and Labeling Practices

Reference sources consistently point to labeling as a practical part of shelf-life tracking. A vial that has been reconstituted is typically marked with the date of mixing and the diluent volume used, since neither piece of information is recoverable by looking at the vial later. This labeling practice is separate from the chemistry of degradation, but it is what allows anyone reviewing a vial’s documentation to compare its age against the storage-condition ranges listed above.

Suppliers in this space, including catalogues referenced through outlets like heezresearch.com/, generally publish reconstitution and storage notes alongside vial specifications, since concentration and shelf-life figures are tied to the specific vial strength being sold. Cross-referencing a given vial’s printed strength against its accompanying documentation is a routine step in interpreting any reconstituted tesamorelin shelf life figure correctly.

Visual and Physical Indicators Reported in Documentation

Beyond elapsed time, reference documentation commonly lists physical observations as indicators worth noting: clarity of the solution, presence of particulate matter, and any change in color. A solution that has become cloudy, discolored, or contains visible particles is generally flagged in supplier literature as outside expected appearance, independent of how many days have elapsed since reconstitution. These indicators are described as a supplement to, not a replacement for, tracking storage time and temperature.

Comparing Reconstituted vs. Lyophilized Storage

Form	Typical storage temperature cited	Typical shelf-life order of magnitude
Lyophilized (powder)	Frozen or refrigerated, dark	Months
Reconstituted (solution)	Refrigerated	Days to weeks

This table reflects general patterns found across supplier and reference documentation rather than a single authoritative figure, since exact numbers vary by manufacturer, diluent, and storage equipment.

Where to Compare Vial-Specific Figures

Because reconstituted tesamorelin shelf life figures are tied to a specific vial strength and diluent ratio, researchers comparing documentation across sources sometimes cross-reference vial pricing and specification pages, such as those at tesamorelinsale.com or tesamorelincost.com, to see how strength and packaging are described alongside storage guidance. Comparing multiple listings side by side is a reasonable way to identify where storage recommendations agree and where they diverge.

Summary

Reconstituted tesamorelin shelf life is consistently reported as shorter than the shelf life of the lyophilized powder, with refrigerated storage cited most often and room-temperature or freeze-thaw handling generally described as reducing stability further. Tracking the reconstitution date, diluent volume, and resulting concentration on the vial label is a recurring theme across supplier and reference documentation, and it is what allows the storage-condition ranges discussed above to be applied to any individual vial.